Login / Signup

Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features.

Nong YangHai-Lin YueBai-Hua ZhangJuan ChenQian ChuJian-Xin WangXiao-Ping YuLian JianYa-Wen BinSi-Ye LiuJin LiuLiang ZengHai-Yan YangChun-Hua ZhouWen-Juan JiangLi LiuYong-Chang ZhangYi XiongZhan Wang
Published in: Thoracic cancer (2023)
NACIP may be a potential model for the early prediction of pCR in patients with NSCLC treated with neoadjuvant/conversion CIT.
Keyphrases